Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a ...

Biolojic Design, a biotechnology company that uses AI to transform antibodies into multifunctional, programmable medicines, ...

Lineage’s COR1 targets restoration of endothelial pump function via intracameral delivery and adhesion to Descemet membrane, ...

“Editas Medicine is making significant progress towards the clinic with our in vivo medicines in preclinical development for people living with serious diseases,” said Linda C. Burkly, Ph.D., ...

By incorporating these advanced models into preclinical packages for the FDA, researchers can provide a much stronger proof ...

The current quarter featured the announcement of a $35.75 million private placement to support EBD program development and a clear target for an IND filing in mid-2027.

This breakthrough has accelerated peptide drug development across multiple therapeutic areas, including cardiovascular ...

Ipsen is back with its second antibody-drug conjugate (ADC) deal of the year, this time signing a $1 billion biobucks pact with Foreseen Biotechnology for a preclinical solid tumor candidate. The ...

Fractyl Health to present preclinical data on gene therapy for obesity and type 2 diabetes at ADA’s Scientific Sessions. Fractyl Health, Inc. has announced it will present new preclinical data from ...

LILLE, France & PARIS--(BUSINESS WIRE)--Regulatory News: Dev4All, 4P-Pharma's cutting-edge R&D booster, announces a strategic collaboration with Pharmaseed, an established Contract Research ...